CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 study evaluating dual therapy with CP-195543 and celecoxib in rheumatoid arthritis was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: TERMINATED | Results posted: 2014-09-25